성심바이오
성심바이오's KOBDi Score is 11.46 as of Sep 2026, up 0.16 points since Apr 2025; it rose in 1 of the 12 monthly updates and never fell. As of Sep 2026 it is ahead of about 29% of companies in its industry, against 29% in Aug 2026 and 29% in Apr 2025. Its strongest position was 29% (Sep 2026) and its weakest 27% (Aug 2025).
A year earlier, in Aug 2025, its score was 11.30 and it was ahead of about 27% of companies in its industry.
| Sep 2026 | 11.46 | ahead of 29% |
| Aug 2026 | 11.46 | ahead of 29% |
| Jul 2026 | 11.46 | ahead of 29% |
| Jun 2026 | 11.46 | ahead of 29% |
| May 2026 | 11.46 | ahead of 29% |
| Apr 2026 | 11.46 | ahead of 29% |
| Mar 2026 | 11.46 | ahead of 29% |
| Feb 2026 | 11.46 | ahead of 29% |
| Dec 2025 | 11.30 | ahead of 29% |
| Aug 2025 | 11.30 | ahead of 27% |
| Jul 2025 | 11.30 | ahead of 27% |
| May 2025 | 11.30 | ahead of 27% |
| Apr 2025 | 11.30 | ahead of 29% |
Where is 성심바이오 located?
성심바이오 is registered at 서울특별시 은평구 응암로16길 16,, South Korea (postal code 03467).
What industry is 성심바이오 in?
성심바이오 belongs to Wholesale & Retail Trade › Non‑store & Vending Retail › Other non-store retail businesses.
How many employees does 성심바이오 have?
성심바이오 has 1–4 employees.
What is 성심바이오's KOBDi Score?
11.46 as of September 2026, ahead of about 29% of companies in its industry.
Who are 성심바이오's competitors?
Similar companies include 모라도, 엔와이스튜디오 and 여래나.

